CRSP vs DNA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 03, 2026
CRSP
53.0
AI Score
VS
It's a Tie!
DNA
53.0
AI Score
Investment Advisor Scores
DNA
53score
Recommendation
HOLD
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | CRSP | DNA | Winner |
|---|---|---|---|
| Revenue | 11.64M | 19.47M | DNA |
| Net Income | -214.09M | -82.59M | DNA |
| Net Margin | -1839.4% | -424.1% | DNA |
| Operating Income | -247.52M | -71.37M | DNA |
| ROE | -12.3% | -18.6% | CRSP |
| ROA | -8.1% | -8.0% | DNA |
| Total Assets | 2.65B | 1.03B | CRSP |
| Cash | 291.34M | 143.86M | CRSP |
| Current Ratio | 17.85 | 5.15 | CRSP |
| Free Cash Flow | -193.55M | -48.62M | DNA |
Relative Price Performance (Last 90 Days)
CRSP 1M: -17.3%
· 3M: -3.8%
DNA 1M: -14.3%
· 3M: -8.1%
Current Technical Phase
CRSP
NeutralHold
Mixed signals - no dominant trend phase, RSI 48
DNA
NeutralHold
Mixed signals - no dominant trend phase, RSI 56
Fundamentals Snapshot
| Metric | CRSP | DNA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -12.8 | -2.8 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.7% | -0.5% |
| Gross Margin | -116.7% | 0.7% |
| Operating Margin | -89.3% | -3.7% |
| EPS | -6.17 | -5.38 |
| Dividend Yield | — | — |
Frequently Asked Questions
Based on our detailed analysis, CRSP and DNA are evenly matched, both winning 4 key financial metrics each. This is a close call that depends on your specific investment goals.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.